Conference call with Dr. Mithoefer, Rick Doblin and FDA officials, in which we come to tentative agreement to conduct the study in Dr. Mithoefer’s office, as long as we hire both an ER doctor and …
FDA rejects our request, primarily saying that they would like a larger emergency response team.
Investigators: Nicole Maalste, Hans Ossebaard Utrecht, Netherlands Contact: Sponsor: MAPS, Promind Foundation Retrospective survey study with former clients who were treated with drug therapy by Dr. Jan …
Request submitted to FDA to change the location of the treatment sessions from the Medical University of South Carolina (MUSC) to Dr. Mithoefer’s office. We propose renting a “crash cart” …
The Dutch government has announced a small scale cross over trial into the effect of three sorts of medical marijuana, plus a placebo, on 16 patients with multiple sclerosis. Two foundations in Rotterdam, …
Investigators: Dr. Spitzer, et al. University of Ulm, Germany Contact: This study was a double-blind, placebo-controlled investigation of the cognitive and brain activation effects of the isomers of MDE. …
Comment from Rick Doblin: The article reports that medical marijuana research is about to begin for the first time in nearly two decades. However, the article makes a distinction that readers are not likely …
DEA claimed the application was lost. Prof. Craker resubmitted a photocopy but was told in February 2002 that the photocopied application was invalid since it didn’t have an original signature. In …
"University of California at San Diego Gets Approval for Medical Marijuana Study" A California university has received final approval from the federal government for a study on medical marijuana. …
The fourth patient in the Spain MDMA/PTSD dose-response study was treated on November 28, 2001. We have now completed the 50 mgs dose group (3 patients received 50 mgs and 1 received a placebo). The next …
It’s my pleasure to report some excellent news. About 10 AM, Friday, November 2, FDA contacted me to say that MAPS’ MDMA/PTSD protocol was approved. This approval marks the culmination of 16 …
MAPS submitted to the FDA today the protocol for Dr. Michael Mithoefer and Dr. Mark Wagner’s MAPS-supported pilot study into the use of MDMA-assisted psychotherapy in the treatment of patients who …